Nevertheless, recent studies suggested the controversial role of adiponectin as a protective agent in CVD, since increased adiponectin levels were involved in the increased risk of coronary-artery disease [83], atrial fibrillation [84] and heart failure [85], as well as raised levels were not linked to higher stroke risk [86,87]. This evidence concerns the gene ADIPOQ and stroke disorder.